Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.The Bank of Korea increased its liquidity to try to calm the market sentiment, and the Bank of Korea increased its capital injection into the financial market, promising to provide "unlimited liquidity" after the political turmoil intensified. According to the website of the Bank of Korea, the liquidity increased by 14.1 trillion won ($9.8 billion) through repurchase operations last week. The scale of such operations was 18.5 trillion won in November and only 1.5 trillion won in October.SpaceX is valued at about $350 billion due to internal stock sales. According to an email sent to employees seen by the media, SpaceX and its investors have agreed to acquire the company's common stock of up to $1.25 billion at a price of $185 per share. This transaction values the rocket and satellite manufacturer owned by elon musk at about $350 billion. The memo said that the price of $185 per share was much higher than the valuation of $112 less than three months ago. The memorandum was further confirmed by insiders. According to the memo, only SpaceX offered to buy up to $500 million in common stock.
South Korean Finance Minister and US Treasury Secretary Yellen confirmed that they will work closely together.Meituan Enterprise Edition released the SIMPLE model: to meet the demands of enterprise consumption compliance, cost reduction and efficiency improvement, and experience improvement. Meituan Enterprise Edition held the second enterprise consumption management conference of "SIMPLE Activating Enterprise Endogenous Force" in Shanghai. At the meeting, Renmin University Business School, Meituan Enterprise Edition, Meituan Research Institute and Ipsos jointly released the SIMPLE model, focusing on serving enterprise consumption management and digital transformation. At present, the scale of consumption expenditure of enterprises in China has reached trillion level, and "integration of supply chain, scene management and control, and service performance" will become the key to competition in the future. (Sina Technology)The commander of Syrian democratic forces said that under the mediation of the US, Syrian rebels and Syrian democratic forces reached a ceasefire agreement in the northern city of Mambiji.
ZTE signed a strategic cooperation agreement with Daiyu and Midea Group. Recently, ZTE signed a strategic cooperation agreement with Daiyu and Midea Group in Chengdu. In the future, the two sides will carry out in-depth cooperation in VR space, AR application and MR interaction.Nine associations, including China Consumers Association and internet society of china, China Hotel Association, China Self-employed Workers Association, china electronic chamber of commerce, China Packaging Federation, China Chain Store & Franchise Association, China Baked Food and Sugar Products Industry Association and China Nutrition Society, jointly proposed on December 11 to encourage catering industry operators (including self-employed workers) to curb catering waste in the industry through innovative measures, public welfare publicity and optimized services.Oppenheimer: Raise the target price of opening customers from $980 to $1,075, and reiterate the rating of "outperforming the market".
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13